Markets:

Overview

News

Currencies

International

Treasuries

Tandem Diabetes Care, Inc. - Common Stock (NQ:TNDM)

17.14 +0.03 (+0.18%)

Streaming Delayed Price Updated: 12:46 PM EDT, Sep 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Where Tandem Diabetes Care Stands With Analysts ↗

September 07, 2022

Tandem Diabetes Care (NASDAQ:TNDM) has observed the following analyst ratings within the last quarter:

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

September 01, 2022

On Thursday, 529 companies set new 52-week lows.

Via Benzinga

Tandem Diabetes' Q1 Bottom-Line Slide Deeper Into Red Despite Sales Growth ↗

May 05, 2022

Via Benzinga

Tandem Diabetes Care Announces Upcoming Conference Presentations

August 22, 2022

From Tandem Diabetes Care, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Thursday ↗

August 18, 2022

During Thursday's trading, 62 companies set new 52-week lows.

Via Benzinga

Tandem Diabetes Care Achieves Milestone of 1 Million Insulin Boluses Delivered Using Its t:connect Mobile App

August 18, 2022

From Tandem Diabetes Care, Inc.

Via Business Wire

Micron Technology, Novavax, CarGurus And Some Other Big Losers From Tuesday ↗

August 10, 2022

U.S. stocks closed lower, with the Nasdaq dropping 150 points on Tuesday. Here is the list of some big stocks moving lower in the previous session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2022 ↗

August 09, 2022

Via Benzinga

NVIDIA To $240? Here Are 5 Other Price Target Changes For Tuesday ↗

August 09, 2022

Raymond James cut the price target on NVIDIA Corporation (NASDAQ: NVDA) from $250 to $240. Raymond James analyst Melissa Fairbanks maintained the stock with a Strong Buy. NVIDIA shares fell 2.8% to...

Via Benzinga

Clorox, Crocs And Some Other Big Stocks Moving Lower On Thursday ↗

August 04, 2022

AMTD Digital Inc. (NYSE: HKD) dipped 43.6% to $620.00 on possible profit taking after the stock surged over the last few trading days.

Via Benzinga

Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday ↗

August 05, 2022

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share...

Via Benzinga

Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session ↗

August 04, 2022

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.

Via Benzinga

What 4 Analyst Ratings Have To Say About Tandem Diabetes Care ↗

August 04, 2022

Analysts have provided the following ratings for Tandem Diabetes Care (NASDAQ:TNDM) within the last quarter:

Via Benzinga

Tandem Diabetes Care: Q2 Earnings Insights ↗

August 03, 2022

Tandem Diabetes Care (NASDAQ:TNDM) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Tandem Diabetes Care Announces Second Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance

August 03, 2022

From Tandem Diabetes Care, Inc.

Via Business Wire

Tandem Diabetes Care Acquires Infusion Set Developer, Capillary Biomedical

July 21, 2022

From Tandem Diabetes Care, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Wednesday ↗

July 13, 2022

During Wednesday's session, 326 stocks hit new 52-week lows.

Via Benzinga

Tandem Diabetes Care to Announce Second Quarter 2022 Financial Results on August 3, 2022

July 12, 2022

From Tandem Diabetes Care, Inc.

Via Business Wire

Tandem Diabetes Care Welcomes Two New Members to Board of Directors

June 16, 2022

From Tandem Diabetes Care, Inc.

Via Business Wire

Control-IQ Technology Continues to Demonstrate Positive and Sustained Real-World Benefits Across Diverse Cohorts of People with Diabetes

June 06, 2022

From Tandem Diabetes Care, Inc.

Via Business Wire

Dexcom Pops After Insulet Buyout Rumor Shakes Up Diabetes Stocks ↗

May 31, 2022

The deal would have been transformative, but may have limited teamwork in the space.

Via Investor's Business Daily

How The Rumored Dexcom-Insulet Marriage Could Rock The Entire Diabetes Space ↗

May 24, 2022

One analyst called the rumored deal "transformative," but says the timing is unfavorable.

Via Investor's Business Daily

Stocks That Hit 52-Week Lows On Tuesday ↗

June 14, 2022

On Tuesday, 951 companies hit new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

May 24, 2022

On Tuesday, 540 companies set new 52-week lows.

Via Benzinga

Tandem Diabetes Care Announces Upcoming Virtual Conference Presentation

May 18, 2022

From Tandem Diabetes Care, Inc.

Via Business Wire

83 Biggest Movers From Yesterday ↗

May 06, 2022

Gainers Hudson Technologies, Inc. (NASDAQ: HDSN) shares jumped 26.9% to close at $9.06 on Thursday after the company reported better-than-expected Q1 EPS and sales results.

Via Benzinga

6 Analysts Have This to Say About Tandem Diabetes Care ↗

May 05, 2022

Within the last quarter, Tandem Diabetes Care (NASDAQ:TNDM) has observed the following analyst ratings:

Via Benzinga

57 Stocks Moving In Thursday's Mid-Day Session ↗

May 05, 2022

Gainers

Via Benzinga

Recap: Tandem Diabetes Care Q1 Earnings ↗

May 04, 2022

Tandem Diabetes Care (NASDAQ:TNDM) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Via Benzinga

Tandem Diabetes Care Announces First Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance

May 04, 2022

From Tandem Diabetes Care, Inc.

Via Business Wire

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.